SEC Form 4 · accession 0001246360-16-005456
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph E Turk Jr.
Officer — President
Period of report
Apr 5, 2016
Accepted (ET)
Apr 6, 2016 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 5, 2016 | M | 1,000 | $9.96 | A | 109,280 | D | |
| Common Stock | Apr 5, 2016 | S | 2,500 | $15.05 | D | 106,780 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $9.96 | Apr 5, 2016 | M | 1,000 | D | Apr 3, 2010 | Mar 2, 2017 | Common Stock | 1,000 | 6,096 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2015.